PharmaCyte CSO resigns; board sets annual meeting Dec 28, continues $10M buyback

PharmaCyte Biotech, Inc.

CSO Gerald W. Crabtree resigned effective Oct 12, 2022; receives $29,694.88 in accrued wages, PTO, and 3 months base salary.
Board set 2022 Annual Meeting for Dec 28, 2022; director nominations due by Oct 28, 2022.
Board authorized continuation of up to $10M stock repurchase program; adopted 10b5-1 plan on Oct 13, 2022.

item 5.02 item 5.08 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gerald W. Crabtree

Chief Scientific Officer

PMCB · PharmaCyte Biotech, Inc.

Effective: 2022-10-12
Filed: October 14, 2022, 7:59 PM ET

On October 12, 2022 (the “Separation Date”), Gerald W. Crabtree, the Chief Scientific Officer of PharmaCyte Biotech , Inc. ( the “Company”), resigned from his position as an employee of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gerald W. Crabtree resigned as Chief Scientific Officer at PharmaCyte Biotech, Inc..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

On October 12, 2022 (the “Separation Date”), Gerald W. Crabtree, the Chief Scientific Officer of PharmaCyte Biotech , Inc. ( the “Company”), resigned from his position as an employee of the Company.

View on SEC.gov

PharmaCyte Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-006911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.